RBC Capital raised the firm’s price target on UiPath (PATH) to $14 from $12 and keeps a Sector Perform rating on the shares as part of a broader ...

UiPath is entering a new market for AI solutions through strategic partnerships that will take it to the next level of ...

On Monday, UiPath PATH got a positive adjustment to its Relative Strength (RS) Rating, from 79 to 82. Please watch the video ...

Palantir ( PLTR +1.65%) and UiPath ( PATH +1.20%) are both well poised to profit from the secular expansion of the artificial ...

A number of stocks fell in the morning session after markets became increasingly wary of high valuations following a ...

UiPath's consensus analyst price target has been modestly increased to $13.71 per share following the latest updates. This shift comes as experts weigh recent product announcements and revenue beats, ...

UiPath (PATH) closed at $14.37 in the latest trading session, marking a +1.2% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.21%. On the other hand, the ...

The stock jumped 13% on that day, and continued to gained from there, peaking on Oct. 9, up 18.8% as Time magazine called ...

UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. 10 stocks we like ...

In recent days, SEC filings revealed that UiPath CEO Daniel Dines sold 45,000 shares as part of a pre-arranged trading plan, adding to a year-long pattern of insider selling with no reported insider ...